68599-6302 NDC - SILVER NITRATE POTASSIUM NITRATE (SILVER NITRATE APPLICATORS)

Drug Information

Product NDC: 68599-6302

Proprietary Name: SILVER NITRATE POTASSIUM NITRATE

Non Proprietary Name: Silver Nitrate Applicators

Active Ingredient(s):
  • 75 mg/g POTASSIUM NITRATE;
  • 25 mg/g SILVER NITRATE


Administration Route(s): TOPICAL

Dosage Form(s): STICK

Labeler Information

Labeler Name: McKesson Medical-Surgical
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number:
Marketing Category: UNAPPROVED DRUG OTHER
Start Marketing Date:3/16/2018
End Marketing Date:1/11/2026

Package Information

No. Package Code Package Description Billing Unit
168599-6302-910 BOX in 1 CASE (68599-6302-9) / 10 VIAL in 1 BOX (68599-6302-8) / 25 g in 1 VIAL (68599-6302-7)

NDC Record

Field Name Field Value Definition
PRODUCT NDC68599-6302The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN PRESCRIPTION DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMESILVER NITRATE POTASSIUM NITRATEThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMESilver Nitrate ApplicatorsThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMESTICKThe translation of the dosage form Code submitted by the firm.
ROUTE NAMETOPICALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE3/16/2018This is the date that the labeler indicates was the start of its marketing of the drug product.
END MARKETING DATE1/11/2026This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
MARKETING CATEGORY NAMEUNAPPROVED DRUG OTHERProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEMcKesson Medical-SurgicalName of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEPOTASSIUM NITRATE; SILVER NITRATEAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH75; 25 
ACTIVE INGRED UNITmg/g; mg/g 

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 2/1/2023